Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

A new method was developed to purify finasteride for better medical use.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

The compounds tested could potentially treat hair loss and alopecia.

A new, simple, and accurate method was created to measure finasteride in tablets.

Compound 4 is a promising treatment for hair loss with low toxicity.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Low-dose finasteride may cause muscle weakness and eye issues, but stopping the drug can lead to recovery.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

PPCM microspheres allow controlled finasteride release over 24 hours.

Researchers developed a quick and sensitive way to measure finasteride in blood using a small sample size.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Finasteride safely lowers DHT levels without affecting testosterone.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.